U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...

Securing a prescription for GLP-1s can be pricey — and not to mention, sometimes quite frustrating and invasive. But safety ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Ozempic-curious people are taking a novel approach to using the blockbuster weight loss drug — and some doctors are even ...

If you've been trying to reach a healthier weight, you may be considering semaglutide medications like Ozempic and Wegovy.

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Highlights,The GLP-1 market for obesity and diabetes treatments is gaining momentum, with Novo Nordisk and Eli Lilly leading ...

Analysts at JPMorgan Chase & Co. last week flagged that Novo Nordisk’s third-quarter results in November may show slower-than ...

The TV world is a jungle for content producers, distributors, brands and consumers. Maybe an answer to our video woes lies in ...